For diabetes patients, A1c reductions of approximately 1.0-1.5 percentage points are common with GLP-1 receptor agonists, while tirzepatide has shown reductions of up to 2.0-2.3 percentage points in clinical trials
A patient should always be given lifestyle recommendations when starting a GLP-1, as this will optimize the results when taking the medication, says Holly Lofton, MD, director of NYU Langones Medical Weight Management Program in New York City
About Ecnoglutide Ecnoglutide injection, originally discovered and developed by Sciwind Biosciences, is the world's first approved cAMP-biased GLP-1 receptor agonist enhancing clinical efficacy and accessibility
But a newer drug called retatrutide is generating real excitement in the medical community, and for good reason
But if you anticipate losing weight on a GLP-1, its a good idea to start your revamped skincare routine in tandem with the medication
But not everyone wants to take medications for weight loss
